Backing the applied sciences and technologies that will power a new economy

Tej Kohli is a visionary entrepreneur and investor with a track record for spotting new global trends and investing early.


Investing in prime and prestige property located within global tech clusters

Tej Kohli has a well-publicised mission to eradicate avoidable blindness worldwide by 2030.


A public mission to cure corneal blindness worldwide by 2030


Targeting major investments into AI, robotics, genomics and esports


Tej Kohli is a technology and real estate entrepreneur, businessman and philanthropist who backs visionary ventures and investments that have the potential to transform lives and change the world. Through investment vehicle Kohli Ventures, Tej Kohli targets high-impact investments into AI, robotics, biotech and genomics opportunities that will help to solve the world’s most pressing challenges and create a better tomorrow. Tej is also a lead investor in the Esports Venture Fund, which is the primary backer of one of the world’s biggest esports teams: Team Vitality.

Tej has a well-publicized mission to cure corneal blindness worldwide by 2035 through the philanthropic Tej Kohli Foundation. The Foundation is an interdisciplinary global hub for humanitarian technologists who are developing solutions to major global health challenges whilst also making direct interventions that transform individual lives around the world. The Tej Kohli Foundation segments its activities into key areas including Cornea Institute, Cornea Program, Applied Research and Impact Initiatives.

Tej Kohli is a Distinguished Alumni of the prestigious Indian Institute of Technology in Kanpur (IITK) where he completed a degree in Electrical Engineering. He first rose to success building innovative white label solutions for technology businesses during the peak of the dot com boom before becoming a prolific entrepreneur and real estate investor in Germany, India and the UAE.

Read More

Featured Story

Philanthropist Tej Kohli pledges $2 million gift to champion biotech solutions for eliminating corneal blindness worldwide by 2030

Popular Stories